The dossier of the Italian Medicines Agency and the Istituto Superiore di Sanità.

The Italian Medicines Agency (Agenzia italiana del farmaco, AIFA) is the public institution responsible for the regulatory activity of pharmaceuticals in Italy.

Feb 13, 2024 · AIFA, the Italian medicines agency, has recently embarked on a significant reform: a process of restructuring governance to promote investments in pharmaceutical research and development and accelerate drug approval processes. Here are the details.

Nov 19, 2024 · The Italian Medicines Agency, known as AIFA (Agenzia Italiana del Farmaco), serves as the central regulatory authority responsible for safeguarding public health through the regulation of pharmaceutical products in Italy.

The Italian Medicines Agency (AIFA) promotes good health through medicines by setting pharmaceutical policies and assuring their consistent application nationwide. AIFA promotes pharmaceutical research and development to further the safety and efficiency of drugs and medical devices.

Dec 30, 2024 · The Italian Medicines Agency approved the new Regulations on conflict of interest, after incorporating suggestions from the Italian National Anti-Corruption Authority. Key takeaways .

Dec 5, 2022 · Giorgio Palú, President of the Italian Medicines Agency (AIFA) helps us understand how the agency works, explains the criteria they use to evaluate innovative medicines and tells us about AIFA’s independent research program.

6 days ago · In this paper, an analysis of pharmacogenetic information in the summary of product characteristics (SmCPs) of drugs approved by Italian Drug Agency (AIFA) was conducted.

Jan 2, 2024 · The Italian Medicines Agency - AIFA is a public body operating according to the principles of autonomy, transparency and efficiency, under the direction of the Ministry of Health and the supervision of the Ministry of Health and the Ministry of Economy.

The Italian Medicines Agency (AIFA) is the national authority responsible for drugs regulation in Italy. The mission of the Agency is to: Promote good health through medicines. Set fair pharmaceutical policies and assure their consistent application nationwide. Manage the value and cost of medicines. Promote pharmaceutical research and development.